Product Images Lovastatin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Lovastatin NDC 68788-8287 by Preferred Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

lovastatin - 65abb8c3 847f 4fb3 b8de 21888c01210b 01

lovastatin - 65abb8c3 847f 4fb3 b8de 21888c01210b 01

Figure 1 - 65abb8c3 847f 4fb3 b8de 21888c01210b 02

Figure 1 - 65abb8c3 847f 4fb3 b8de 21888c01210b 02

The text describes a figure labeled "Figure 1" which displays data on the proportion of participants without acute major coronary events over time. The primary endpoint is a risk reduction of approximately 87%, with a significance level of p<0.009. The figure shows data for years of follow-up.*

Lovastatin Tablets USP 10mg - 8A77E539 A31E 43A4 A53E A4204AA38558 00

Lovastatin Tablets USP 10mg - 8A77E539 A31E 43A4 A53E A4204AA38558 00

This is a medication description for Lovastatin Tablets, USP 10mg, which is a generic version of Mevacor. The tablets are green and oval in shape, and each tablet contains 10mg of Lovastatin, which is used to lower cholesterol and triglyceride levels. The medication should only be taken by the person to whom it was prescribed, and caution should be taken to keep it out of the reach of children and protect it from light. The tablets are manufactured by Lupin Pharmaceuticals, Inc., and the packaging includes information on the lot and batch numbers, as well as the expiration date. A billing chart log is also mentioned.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.